Confirmatory versus explorative endpoint analysis: decision-making on the basis of evidence available from market authorization and early benefit assessment for oncology drugs
Source: Health Policy - Category: Health Management Authors: Ines Niehaus, Charalabos-Markos Dintsios Source Type: research
More News: Cancer & Oncology | Health Management